News Search

32 results Number of Results per Page
  1. ThromboGenics and Vlerick team up on business model innovation

    Date:
    Category: Partner News

    The biopharmaceutical company ThromboGenics is a Belgian success story. Despite a headcount of only about 200, the company has a worldwide reach. In March 2013 its shares were included in the BEL 20. Why a Prime Foundation Partnership? Patrik De Haes, CEO at ThromboGenics, explains.

32 results Number of Results per Page

Accreditations
& Rankings

Equis Association of MBAs AACSB Financial Times